Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
04/10/1990 | EP0359739A4 Tranforming growth factor-beta. |
04/10/1990 | EP0268663A4 Phosphopeptides. |
04/10/1990 | CA1267620A1 Cell lines and their use for the production of proteins |
04/10/1990 | CA1267615A1 Method for recovering purified growth hormones from genetically engineered microorganisms |
04/10/1990 | CA1267602A1 Composition containing tissue plasminogen activator |
04/07/1990 | CA2000340A1 Peptidase inhibitors |
04/07/1990 | CA2000337A1 Chemical compounds |
04/07/1990 | CA2000263A1 Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells |
04/07/1990 | CA2000254A1 Stabilized compound of fgf-family growth factors and dextran sulfate and it a applications |
04/05/1990 | WO1990003436A1 tPA-LIKE POLYPEPTIDES, THEIR MANUFACTURE AND USE |
04/05/1990 | WO1990003435A2 Nucleic acid coding for the human angiotensine conversion enzyme (ace), and its applications particularly for the in vitro diagnosis of high blood pressure |
04/05/1990 | WO1990003434A1 Recombinant dna coding for bacillus thuringiensis endotoxin |
04/05/1990 | WO1990003433A1 Vaccine |
04/05/1990 | WO1990003400A1 Intercellular adhesion molecules, and their binding ligands |
04/05/1990 | WO1990003399A1 Amino acid transport proteins, amino acid analogues, assay apparatus, uses thereof for treatment and diagnosis of cancer |
04/05/1990 | WO1990003398A1 Capsular polysaccharide adhesin antigen, preparation, purification and use |
04/05/1990 | WO1990003397A1 Novel megakaryocytic colony stimulating factor and process for its preparation |
04/05/1990 | WO1990003396A1 Dna damage-binding factor and uses therefor |
04/05/1990 | WO1990003395A1 Novel physiologically active polypeptide, recombinant plasmid, recombinant microbial cells, medicinal composition, and process for recovering purified polypeptide |
04/05/1990 | WO1990003394A2 New limphokines, dna sequences coding for said limphokines and pharmaceutical compositions containing said limphokines |
04/05/1990 | WO1990003393A1 Crf analogs |
04/05/1990 | WO1990003392A1 Crf antagonists |
04/05/1990 | WO1990003391A1 Hirudin peptides |
04/05/1990 | WO1990003390A1 Peptidyl inhibitors of the initiation of coagulation |
04/05/1990 | WO1990003389A1 Renin inhibitory peptides containing maleamide substituents |
04/05/1990 | WO1990003388A1 A preparation of plasminogen activator expressed in prokaryonts |
04/05/1990 | WO1990003189A1 Use of gamma-interferon for the treatment of vascular stenosis |
04/05/1990 | WO1990003186A1 Gram-negative bacterial endotoxin blocking monoclonal antibodies |
04/05/1990 | WO1990003185A1 Combination enzyme immunotherapeutics |
04/05/1990 | WO1990003182A1 Method and composition for preventing conception |
04/05/1990 | WO1990003181A2 Peptide antagonists for use in cancer therapy, and the use of mas oncogene and its product |
04/05/1990 | WO1990003180A1 Peptides having t cell suppressor activity |
04/05/1990 | WO1990003164A2 Pharmaceutical formulations |
04/05/1990 | DE3924887A1 Insulin filled pill - made of plastic material insol. by digestive juices |
04/05/1990 | CA2000228A1 Monoclonal antibody which recognizes a pre-si region of the large surface protein of the hepatitis b virus and its explications, especially for the in vitro diagnostic and the treatment of hepatitis b |
04/04/1990 | EP0362002A1 HIV protease inhibitors |
04/04/1990 | EP0361991A2 Method for the microbiological preparation of human serum albumin and other heterologous proteins from a yeast |
04/04/1990 | EP0361977A2 Peptides having T cell suppressor activity |
04/04/1990 | EP0361957A1 Tissue equivalents and methods of preparation thereof |
04/04/1990 | EP0361954A2 CRF Analogs |
04/04/1990 | EP0361908A2 Combination enzyme immunotherapeutics |
04/04/1990 | EP0361720A1 Hemoglobin-based blood substitute and method for the preparation thereof |
04/04/1990 | EP0361719A1 Haemoglobin based blood substitute and method for the preparation thereof |
04/04/1990 | EP0361475A1 Preparation of a plasminogen activator expressed in procaryotic cells |
04/04/1990 | EP0361348A1 Non-steroidal pharmaceutical composition and process for producing the same |
04/04/1990 | EP0361341A2 Therapeutics for aids based on inhibitors of HIV protease |
04/04/1990 | EP0361284A2 T cell growth factor |
04/04/1990 | EP0361077A2 Use of PAF antagonists in the treatment of autoimmune disorders |
04/04/1990 | EP0360840A1 Cytolytic factor |
04/04/1990 | CN1040926A Cell growth inhibitory factor |
04/03/1990 | US4914214 Condensing esterified 2-carboxyperhydroindole with specific isomer of n-(1-carbethoxybutyl)-alanine, deesterifying, forming salt |
04/03/1990 | US4914189 Synthetic GHRH analogs |
04/03/1990 | US4914188 Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin |
04/03/1990 | US4914090 Intraocular pressure reduction by administering hydrocortisone and angiotensin converting enzyme inhibitor |
04/03/1990 | US4914088 Dry eye treatment solution and method |
04/03/1990 | US4914087 Nikkomycin derivatives, antimycotic compositions of nikkomycin derivatives and azole antimycotics |
04/03/1990 | US4914033 Structure and properties of modified interferons |
04/03/1990 | US4914027 Process for the microbiological preparation of human serum albumin |
04/03/1990 | US4914021 Kit for screening colorectal cancer |
04/03/1990 | US4913908 Polymerizing alkyl cyanoacrylate in aqueous suspension of biologically active material without surfactant |
04/03/1990 | US4913904 Isolated from animal eyes |
04/03/1990 | CA2000048A1 Peptides and antibodies that inhibit integrin-ligand bindin g |
04/03/1990 | CA2000044A1 Monoclonal antibodies against receptor induced binding sites |
04/03/1990 | CA1267499A1 Peptide amides and aldehydes |
04/03/1990 | CA1267498A1 Renin-inhibitory peptides and their use |
04/03/1990 | CA1267497A1 Protein recovery |
04/03/1990 | CA1267374A1 Enhanced inhibition of yeast cell growth |
03/29/1990 | DE3832713A1 Colony stimulating factor (= CSF) |
03/28/1990 | EP0360760A2 Pipecolic acid containing cyclopeptolides, their preparation and pharmaceutical compositions containing them |
03/28/1990 | EP0360481A1 New pentapeptide and a process for the preparation thereof |
03/28/1990 | EP0360433A1 Protein derivatives and a process for their preparation |
03/28/1990 | EP0360411A1 O-glycosylated IGF-1 |
03/28/1990 | EP0360390A1 Spirolactam derivatives |
03/28/1990 | EP0360340A1 Composition for nasal administration containing a peptide |
03/28/1990 | EP0360290A2 Process for producing a novel antifungal product |
03/28/1990 | EP0360258A2 Amino acid quinoline and naphthyridine derivatives |
03/28/1990 | EP0360226A2 Drug for testing function of secreting adrenocorticotropic hormone |
03/28/1990 | EP0360191A2 Anti-aids virus composition |
03/28/1990 | EP0360006A2 Acid-resistant fibroblast growth factor composition for treating ulcerating diseases of the gastrointestinal tract |
03/28/1990 | EP0359998A2 Factor regulating gene expression |
03/28/1990 | EP0359873A1 Method of treating mastitis and other staphylococcal infections |
03/28/1990 | EP0359781A1 Immunosuppressive polypeptides |
03/28/1990 | EP0359739A1 Tranforming growth factor-beta. |
03/28/1990 | CN1040741A Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
03/28/1990 | CN1007318B Method suitable for natural fertilization or insemination to produce new generation from mammal |
03/27/1990 | USRE33188 Peptides for assaying human parathyroid hormone |
03/27/1990 | US4912201 Monoclonal antibodies and antisera to intragonadal regulatory protein |
03/27/1990 | US4912127 New 2-acylpyrrolidine derivatives, a process for the preparation thereof, agents containing them, and their use |
03/27/1990 | US4912092 Prevent tissue damage; administering purine nucleoside |
03/27/1990 | US4912045 Hybrid cell line for producing monoclonal antibody to a human monocyte, antigen, antibody and methods |
03/27/1990 | US4912038 Recombinant DNA sequence encoding alveolar surfactant protein |
03/27/1990 | US4911929 Blood substitute comprising liposome-encapsulated hemoglobin |
03/27/1990 | US4911918 Oral composition containing stabilized antibody |
03/27/1990 | US4911912 Treatment of glycoprotein with periodate and cyanoborohydride |
03/27/1990 | US4911911 Treatment of glycoprotein with periodate in presence of amine |
03/27/1990 | US4911910 Purified equine immunologlobulins and method of use thereof |
03/27/1990 | US4911909 Method of controlling hypertension using monoclonal antibodies to angiotensin-II |
03/27/1990 | US4911908 Interferon administration vehicles |
03/27/1990 | CA1267099A1 Secretion of correctly processed human growth hormone in e.coli and pseudomonas |
03/27/1990 | CA1267086A1 Method of administering diuretic atrial peptides |